The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AQUINOX PHARMACEUTICALS INC | COM | 03842B101 | 4,434 | 312,500 | SH | OTR | 1 | 312,500 | 0 | 0 | |
| ARADIGM CORP | COM PAR | 038505400 | 2,100 | 500,000 | SH | OTR | 1 | 500,000 | 0 | 0 | |
| AVEXIS INC | COM | 05366U100 | 77,384 | 800,000 | SH | OTR | 1 | 800,000 | 0 | 0 | |
| AXOVANT SCIENCES LTD | COM | G0750W104 | 3,440 | 500,000 | SH | OTR | 1 | 500,000 | 0 | 0 | |
| BARCLAYS BK PLC | IPATH S&P 500 VIX | 06746L422 | 1,960 | 50,000 | SH | OTR | 1 | 50,000 | 0 | 0 | |
| BEIGENE LTD | SPONSORED ADR | 07725L102 | 62,076 | 600,000 | SH | OTR | 1 | 600,000 | 0 | 0 | |
| BELLEROPON THERAPEUTICS INC | COM | 078771102 | 2,637 | 1,857,143 | SH | OTR | 1 | 1,857,143 | 0 | 0 | |
| BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 17,418 | 250,000 | SH | OTR | 1 | 250,000 | 0 | 0 | |
| CLOVIS ONCOLOGY INC | COM | 189464100 | 41,200 | 500,000 | SH | OTR | 1 | 500,000 | 0 | 0 | |
| CYMABAY THERAPEUTICS INC | COM | 23257D103 | 8,165 | 1,012,986 | SH | OTR | 1 | 1,012,986 | 0 | 0 | |
| EIGER BIOPHARMACEUTICALS INC | COM | 28249U105 | 1,522 | 138,331 | SH | OTR | 1 | 138,331 | 0 | 0 | |
| ESPERION THERAPEUTICS INC NE | COM | 29664W105 | 25,060 | 500,000 | SH | OTR | 1 | 500,000 | 0 | 0 | |
| G1 THERAPEUTICS INC | COM | 3621LQ109 | 15,660 | 629,179 | SH | OTR | 1 | 629,179 | 0 | 0 | |
| GTX INC DEL | COM NEW | 40052B207 | 4,771 | 565,291 | SH | OTR | 1 | 565,291 | 0 | 0 | |
| KURA ONCOLOGY INC | COM | 50127T109 | 12,630 | 844,789 | SH | OTR | 1 | 844,789 | 0 | 0 | |
| LA JOLLA PHARMACEUTICAL CO | COM PAR $.0001 2 | 503459604 | 9,304 | 267,500 | SH | OTR | 1 | 267,500 | 0 | 0 | |
| MACROGENICS INC | COM | 556099109 | 40,656 | 2,200,000 | SH | OTR | 1 | 2,200,000 | 0 | 0 | |
| MEDICINES COMPANY | COM | 584688105 | 33,336 | 900,000 | SH | OTR | 1 | 900,000 | 0 | 0 | |
| MIRATI THERAPEUTICS INC | COM | 60468T105 | 12,145 | 1,037,994 | SH | OTR | 1 | 1,037,994 | 0 | 0 | |
| NABRIVA THERAPEUTICS AG | SPONSORED ADR | 62957M104 | 710 | 86,710 | SH | OTR | 1 | 86,710 | 0 | 0 | |
| ONCONOVA THERAPEUTICS INC | *W EXP 07/07/202 | 68232V116 | 528 | 308,793 | SH | OTR | 1 | 308,793 | 0 | 0 | |
| ONCONOVA THERAPEUTICS INC | COM NEW | 68232V306 | 92 | 241,644 | SH | OTR | 1 | 241,644 | 0 | 0 | |
| PTC THERAPEUTICS INC | COM | 69366J200 | 25,013 | 1,250,000 | SH | OTR | 1 | 1,250,000 | 0 | 0 | |
| PUMA BIOTECHNOLOGY INC | COM | 74587V107 | 11,975 | 100,000 | SH | OTR | 1 | 100,000 | 0 | 0 | |
| REATA PHARMACEUTICALS INC | CL A | 75615P103 | 6,220 | 200,000 | SH | OTR | 1 | 200,000 | 0 | 0 | |
| REGULUS THERAPEUTICS INC | COM | 75915K101 | 2,747 | 2,197,802 | SH | OTR | 1 | 2,197,802 | 0 | 0 | |
| STRONGBRIDGE BIOPHARMA PLC | SHS USD | G85347105 | 5,913 | 856,900 | SH | OTR | 1 | 856,900 | 0 | 0 | |
| SUNESIS PHARMACEUTICALS INC | COM PAR | 867328700 | 1,989 | 1,025,000 | SH | OTR | 1 | 1,025,000 | 0 | 0 | |
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 1,170 | 100,000 | SH | OTR | 1 | 100,000 | 0 | 0 | |
| ZOGENIX INC | COM NEW | 98978L204 | 7,010 | 200,000 | SH | OTR | 1 | 200,000 | 0 | 0 | |